Persuasivedx
1 known investors
Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.
Investors · 1
Frequently asked questions
- What does Persuasivedx do?
- Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.
- Who are Persuasivedx's investors?
- Persuasivedx's investors include NLC.